Effect of Low-Level Laser Therapy in Treatment of Chemotherapy Induced Oral Mucositis
Journal of Lasers in Medical Sciences,
Vol. 10 No. 2 (2019),
,
Page 125-130
Abstract
Introduction: Oral mucositis (OM) is an unavoidable condition of the oral cavity that accompanies chemotherapy for various malignant cases. Chemotherapy-induced oral Mucositis (COM) is a frequent complication due to mucotoxic drugs and is known to deteriorate the general health significantly, while negatively affecting the quality of life (QOL). Studies have reported that low-level laser therapy (LLLT) promotes the tissue healing. The objective of the present study was to explore the efficacy of gallium-arsenide (GaAs) laser in treating COM and its impact on inflammatory cytokine levels in patients receiving chemotherapy for various malignancies.Methods: A total of 80 patients with COM received LLLT 6 days/week. OM was graded according to the World Health Organization (WHO) grading scale. The outcome parameters were the serum levels of tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) measured before, during and after administration of LLLT.
Results: After LLLT, a significant decrease was found in the mean values of mucositis grade from 2.35 ± 0.695 to 1.13 ± 0.333 after (P < 0.001). A significant reduction in the level of TNF-α was found after LLLT among breast cancer patients (P = 0.0045), but not in head and neck cancer and lymphoma patients. A significant reduction was also found in IL-6 level after treatment among head and neck and breast cancer patients (P = 0.0307 and 0.019, respectively).
Conclusion: The use of GaAs LLLT in treating COM in patients with various malignancies is well tolerated by patients, it results in improvement of mucositis, however; mechanism of action does not seem to be completely linked to the change of pro or anti-inflammatory cytokines.
- Low-level laser therapy
- Oral Mucositis
- Cancer.
How to Cite
References
P. Laser parameters drawn from meta-analysis on the efficacy of LLLT in oral mucositis. Support Care Cancer. 2012; 20(1):1-283. doi:10.1007/s00520-011-1202-0
Campos MI, Campos CN, Aarestrup FM, Aarestrup BJ. Oral mucositis in cancer treatment:Natural history, prevention and treatment. Mol Clin Oncol. 2014;2(3):337- 40. doi:10.3892/mco.2014.253
Jones JA, Avritscher EB, Cooksley CD, Michelet M, Bekele BN, Elting LS. Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer. Support Care Cancer. 2006;14(6):505-15. doi:10.1007/s00520-006-0055- 4
Vigarios E, Epstein JB, Sibaud V. Oral mucosal changes induced by anticancer targeted therapies and immune checkpoint inhibitors. Support Care Cancer. 2017;25(5):1713-9. doi:10.1007/s00520-017-3629-4
Bonomi M. and Batt K. Supportive management of mucositis and metabolic derangements in head and neck cancer patients. Cancers (Basel). 2015;7:1743-57. doi:10.3390/cancers7030862
Gholizadeh N, Sheykhbahaei N, Sadrzadeh-Afshar M. New treatment approaches of oral mucositis: a review of literature. Adv Hum Biol. 2016;6:66-72. doi:10.4103/2321- 8568.190319
Lalla RV, Saunders DP, Peterson DE. Chemotherapy or radiation-induced oral mucositis. Dent Clin North Am. 2014;58(2):341-9. doi:10.1016/j.cden.2013.12.005
Barkokebas A, Silva IH, de Andrade SC, et al. Impact of oral mucositis on oral-health-related quality of life of patients diagnosed with cancer. J Oral Pathol Med. 2015;44(9):746- 51. doi:10.1111/jop.12282
Gobbo M, Ottaviani G, Perinetti G, et al. Evaluation of nutritional status in head and neck radio-treated patients affected by oral mucositis: efficacy of class IV laser therapy. Support Care Cancer. 2014;22(7):1851-1856. doi: 10.1007/ s00520-014-2155-x.
Lalla RV, Bowen J, Barasch A, et al. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2014;120(10):1453- 61. doi:10.1002/cncr.28592
Chaveli-López B, Bagán-Sebastián JV. Treatment of oral mucositis due to chemotherapy. J Clin Exp Dent. 2016;8(2):e201-e209. doi:10.4317/jced.52917
Antunes H, Herchenhorn D, Small I, et al. Phase III trial of low-level laser therapy to prevent oral mucositis in head and neck cancer patients treated with concurrent chemoradiation. Radiother Oncol. 2013;109:297-302.
Robijns J, Censabella S, Bulens P, Maes A, Mebis J. The use of low-level light therapy in supportive care for patients with breast cancer: review of the literature. Lasers Med Sci. 2017;32(1):229-42. doi:10.1007/s10103-016-2056-y
Fekrazad R, Chiniforush N. Oral mucositis prevention and management by therapeutic laser in head and neck cancers. J Lasers Med Sci. 2014;5(1):1-7.
Figueiredo A, Lins L, Cattony A, Falcão A. Laser therapy in the control of oral mucositis:a meta-analysis. Rev Assoc Med Bras (1992). 2013;59(5):467-474. doi:10.1016/j. ramb.2013.08.003
Oberoi S, Zamperlini-Netto G, Beyene J, Treister NS, Sung L. Effect of prophylactic low level laser therapy on oral mucositis: a systematic review and meta-analysis. PLoS One. 2014;9(9):e107418. doi:10.1371/journal. pone.0107418
World Health Organization. Handbook for reporting results of cancer treatment. Genava: World Health Organization; 1979:15-22.
Lanz B, Kostamovaara JT. Current pulse investigation toward optimal pumping of a gain-switched asymmetric waveguide laser diode. Proceedings of SPIE Laser Technology for Defense and Security X Conference (DSS); Baltimore, USA; 5– 9 May 2014: 90810W 1–10.
Arbabi-Kalati F, Arbabi-Kalati F, Moridi T. Evaluation of the effect of low level laser on prevention of chemotherapy-induced mucositis. Acta Med Iran. 2013;51(3):157-162.
Ahmed KM, Hussein SA, Noori AJ, Abdulateef SN, Abdulla BK. Evaluation of low level laser therapy in the management of chemotherapy-induced oral mucositis in pediatric and young cancer patients: a randomized clinical trial. European Scientific Journal. 2015;11(27):209-222.
Amadori F, Bardellini E, Conti G, Pedrini N, Schumacher RF, Majorana A. Low-level laser therapy for treatment of chemotherapy-induced oral mucositis in childhood: a randomized double-blind controlled study. Lasers Med Sci. 2016;31(6):1231-1236.
Ahad A, Tasneem S, Lamba AK, Khan S. Healing of self-inflicted thermal injury of palatal mucosa by low level laser therapy. Spec Care Dentist. 2017;37(6):314-317. doi:10.1111/scd.12256
Logan RM, Stringer AM, Bowen JM, et al. The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs. Cancer Treat Rev. 2007;33(5):448- 460. doi:10.1016/j.ctrv.2007.03.001
Raber-Durlacher JE, von Bültzingslöwen I, Logan RM, et al. Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients. Support Care Cancer. 2013;21(1):343-355. doi:10.1007/ s00520-012-1594-5
Silva GB, Sacono NT, Othon-Leite AF, et al. Effect of low-level laser therapy on inflammatory mediator release during chemotherapy-induced oral mucositis: a randomized preliminary study. Lasers Med Sci. 2015;30(1):117-126. doi:10.1007/s10103-014-1624-2
Usuda J, Okunaka T, Furukawa K, et al. Increased cytotoxic effects of photodynamic therapy in IL‐6 gene transfected cells via enhanced apoptosis. IJC. 2001;39(4):475-80.
de Paula Eduardo F, Bezinelli LM, da Graça Lopes RM, Nascimento Sobrinho JJ, Hamerschlak N, Correa L. Efficacy of cryotherapy associated with laser therapy for decreasing severity of melphalan-induced oral mucositis during hematological stem-cell transplantation:a prospective clinical study. Hematol Oncol. 2015;33(3):152- 158. doi:10.1002/hon.2133
Medeiros-Filho JB, Maia Filho EM, Ferreira MC. Laser and photochemotherapy for the treatment of oral mucositis in young patients: randomized clinical trial. Photodiagnosis Photodyn Ther. 2017;18:39-45. doi:10.1016/j. pdpdt.2017.01.004
- Abstract Viewed: 918 times
- PDF Downloaded: 387 times
